Ratios Reveal: Breaking Down Kura Oncology Inc (KURA)’s Financial Health

Nora Barnes

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

Kura Oncology Inc (NASDAQ: KURA) closed the day trading at $10.74 up 0.66% from the previous closing price of $10.67. In other words, the price has increased by $0.66 from its previous closing price. On the day, 1.48 million shares were traded. KURA stock price reached its highest trading level at $10.82 during the session, while it also had its lowest trading level at $10.52.

Ratios:

For a better understanding of KURA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.70 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.24. For the most recent quarter (mrq), Quick Ratio is recorded 5.12 and its Current Ratio is at 5.12. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.06.

On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $27.UBS initiated its Buy rating on October 24, 2024, with a $27 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 09 ’25 when Hasnain Faheem sold 10,000 shares for $10.98 per share. The transaction valued at 109,764 led to the insider holds 23,983 shares of the business.

FAHEEM HASNAIN bought 10,000 shares of KURA for $116,400 on Dec 09 ’25. On Nov 14 ’25, another insider, Bair Teresa Brophy, who serves as the Chief Legal Officer of the company, sold 8,804 shares for $11.18 each. As a result, the insider received 98,401 and left with 188,139 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KURA now has a Market Capitalization of 934568128 and an Enterprise Value of 404369152. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.98 while its Price-to-Book (P/B) ratio in mrq is 3.85. Its current Enterprise Value per Revenue stands at 3.887 whereas that against EBITDA is -1.692.

Stock Price History:

The Beta on a monthly basis for KURA is 0.25, which has changed by 0.101135135 over the last 52 weeks, in comparison to a change of 0.13042927 over the same period for the S&P500. Over the past 52 weeks, KURA has reached a high of $12.49, while it has fallen to a 52-week low of $5.41. The 50-Day Moving Average of the stock is 2.30%, while the 200-Day Moving Average is calculated to be 39.64%.

Shares Statistics:

Over the past 3-months, KURA traded about 1.93M shares per day on average, while over the past 10 days, KURA traded about 1479000 shares per day. A total of 87.02M shares are outstanding, with a floating share count of 84.37M. Insiders hold about 3.04% of the company’s shares, while institutions hold 96.08% stake in the company. Shares short for KURA as of 1764288000 were 7990490 with a Short Ratio of 4.14, compared to 1761868800 on 8675680. Therefore, it implies a Short% of Shares Outstanding of 7990490 and a Short% of Float of 9.2.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.